1 year return (CAGR)
-93.11%
Adaptimmune Therapeutics Plc Exchange (NASDAQ, USD)
ADAP
-
-0.00 (-7.47%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
13.46M
Price/Sales
0.08
Ent value
134.17M
Price/Book
0.17
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-10.33%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.05 |
| Daily high | 0.05 |
| Daily low | 0.04 |
| Daily Volume | 9.04M |
| 1y analyst estimate | 0.68 |
| Beta | 2.49 |
| EPS (TTM) | -0.18 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 10 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ADAP | S&P500 | |
| Current price drop from All-time high | -99.83% | -1.43% |
| Highest price drop | -99.81% | -56.47% |
| Date of highest drop | 5 Sep 2025 | 9 Mar 2009 |
| Avg drop from high | -98.22% | -10.68% |
| Avg time to new high | - | 12 days |
| Max time to new high | 266 days | 1805 days |
News
No items found